Gastro-esophageal Reflux Disease (GERD) Completed Phase 1 Trials for Lansoprazole (DB00448)

Also known as: Gastroesophageal Reflux Disease / Gastro-esophageal Reflux Disease / GERD / GERD Gastroesophageal Reflux Disease / Gastro-Oesophageal Reflux Disease / Gastrooesophageal reflux disease / GERD (Gastroesophageal Reflux Disease) / Esophageal Reflux / GERD - Gastro-Esophageal Reflux Disease / Gastroesophageal Reflux Disease (GERD) / Gastro-esophageal Reflux Diseases / Oesophageal reflux / Esophagitis / Gastrooesophageal reflux / Gastroesophageal reflux / Esophageal reflux NOS

IndicationStatusPhase
DBCOND0077290 (Gastro-esophageal Reflux Disease (GERD))Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00174928A Study to Evaluate the Effect of Lansoprazole on Hospitalized Neonates With Gastroesophageal Reflux DiseaseTreatment
NCT00220818A Study to Evaluate the Effect of Lansoprazole on Infants With Gastroesophageal Reflux Disease.Treatment